Six-year follow-up from the weekly-three-weekly study comparing cisplatin once-a-week to once-every-three-weeks as concurrent chemoradiation for locally advanced head and neck squamous cell carcinoma.
JOURNAL OF CLINICAL ONCOLOGY(2022)
Key words
cisplatin,concurrent chemoradiation,squamous cell carcinoma,six-year,weekly-three-weekly,once-a-week,once-every-three-weeks
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined